Colin L. Masters
Physiology · 2001–2021
A researcher in the Science corpus: 21 papers; trusts 1 researcher and is trusted by 5 researchers here, as inferred from the citation graph.
Subfields
- Physiology — 219 citations into it; #880 of 2,276 by trust here, #79 by citations
- Nutrition and Dietetics — 5 citations into it
Whom Colin L. Masters trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Colin L. Masters overall
Papers from Colin L. Masters's perspective
Ordered by how strongly the researchers Colin L. Masters trusts endorse each paper. Same corpus, a different order for every researcher.
- Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease (Nature Medicine)
- Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. (Neuron)
- Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease (Nature)
- β-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease
- Voluntary Exercise Decreases Amyloid Load in a Transgenic Model of Alzheimer's Disease (Journal of Neuroscience)
- Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. (Archives of Neurology)
- Are memory complaints predictive for dementia? A review of clinical and population‐based studies (International Journal of Geriatric Psychiatry)
- The Anti Cancer Council of Victoria FFQ: relative validity of nutrient intakes compared with weighed food records in young to middle‐aged women in a study of iron supplementation (Australian and New Zealand Journal of Public Health)
- Hydrogen peroxide signalling. (Current opinion in plant biology)
- Memantine in moderate-to-severe Alzheimer's disease. (New England Journal of Medicine)
Their papers
- Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta. (2008) — 658 citations
- The Amyloid-β Pathway in Alzheimer’s Disease (2021) — 1,619 citations
- MRI signatures of brain age and disease over the lifespan based on a deep brain network and 14 468 individuals worldwide. (2020) — 356 citations
- Harmonization of large MRI datasets for the analysis of brain imaging patterns throughout the lifespan (2019) — 521 citations
- Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease (2019) — 781 citations
- High performance plasma amyloid-β biomarkers for Alzheimer’s disease (2018) — 1,471 citations
- Alzheimer's disease (2015) — 1,237 citations
- Tau imaging: early progress and future directions. (2015) — 465 citations
- Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study. (2013) — 1,951 citations
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer’s Disease (2012) — 3,500 citations
- An iron-export ferroxidase activity of β-amyloid protein precursor is inhibited by zinc in Alzheimer’s Disease (2010) — 660 citations
- Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. (2010) — 1,039 citations
- The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease (2009) — 979 citations
- Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial. (2008) — 655 citations
- Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism. (2008) — 655 citations
- β-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease (2007) — 745 citations
- Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein. (2005) — 657 citations
- Neurodegenerative diseases and oxidative stress (2004) — 3,753 citations
- Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. (2003) — 983 citations
- Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic Mice (2001) — 1,403 citations